Nicotine Pharmacokinetic and Pharmacodynamics Profile, Safety and Tolerability of P3L

Mise à jour : Il y a 4 ans
Référence : NCT02532374

Femme et Homme

  • | Pays :
  • New Zealand
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD, i.e., subjective effects) profiles, and the safety and tolerability of the nicotine-containing aerosol delivered by Platform 3 Liquid (P3L) system at three different nicotine levels in smoking healthy subjects in Relation to Nicorette®.


Critère d'inclusion

  • Smoking

Liens